• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microbiol Spectr . Rapid and Flexible RT-qPCR Surveillance Platforms To Detect SARS-CoV-2 Mutations

tetano

Editor, Senior Moderator
Microbiol Spectr


. 2023 Jan 9;e0359122.
doi: 10.1128/spectrum.03591-22. Online ahead of print.
Rapid and Flexible RT-qPCR Surveillance Platforms To Detect SARS-CoV-2 Mutations


Katja Spiess[SUP] #[/SUP][SUP] 1 [/SUP], Vithiagaran Gunalan[SUP] #[/SUP][SUP] 1 [/SUP], Ellinor Marving[SUP] 1 [/SUP], Sofie Holdflod Nielsen[SUP] 2 [/SUP], Michelle G P Jørgensen[SUP] 2 [/SUP], Anna S Fomsgaard[SUP] 1 [/SUP], Line Nielsen[SUP] 2 [/SUP], Alonzo Alfaro-Núñez[SUP] 1 [/SUP], Søren M Karst[SUP] 1 [/SUP]; Danish COVID-19 Genome Consortium (DCGC); Shila Mortensen[SUP] 1 [/SUP], Morten Rasmussen[SUP] 1 [/SUP], Ria Lassaunière[SUP] 1 [/SUP], Maiken Worsøe Rosenstierne[SUP] 3 [/SUP], Charlotta Polacek[SUP] 1 [/SUP], Jannik Fonager[SUP] 1 [/SUP], Arieh S Cohen[SUP] 2 [/SUP], Claus Nielsen[SUP] 1 [/SUP], Anders Fomsgaard[SUP] 1 [/SUP]



Affiliations

Abstract

Multiple mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) increase transmission, disease severity, and immune evasion and facilitate zoonotic or anthropozoonotic infections. Four such mutations, ΔH69/V70, L452R, E484K, and N501Y, occurred in the SARS-CoV-2 spike glycoprotein in combinations that allow the simultaneous detection of VOCs. Here, we present two flexible reverse transcription-quantitative PCR (RT-qPCR) platforms for small- and large-scale screening (also known as variant PCR) to detect these mutations and schemes for adapting the platforms to future mutations. The large-scale RT-qPCR platform was validated by pairwise matching of RT-qPCR results with whole-genome sequencing (WGS) consensus genomes, showing high specificity and sensitivity. Both platforms are valuable examples of complementing WGS to support the rapid detection of VOCs. Our mutational signature approach served as an important intervention measure for the Danish public health system to detect and delay the emergence of new VOCs. IMPORTANCE Denmark weathered the SARS-CoV-2 crisis with relatively low rates of infection and death. Intensive testing strategies with the aim of detecting SARS-CoV-2 in symptomatic and nonsymptomatic individuals were available by establishing a national test system called TestCenter Denmark. This testing regime included the detection of SARS-CoV-2 signature mutations, with referral to the national health system, thereby delaying outbreaks of variants of concern. Our study describes the design of the large-scale RT-qPCR platform established at TestCenter Denmark in conjunction with whole-genome sequencing to report mutations of concern to the national health system. Validation of the large-scale RT-qPCR platform using paired WGS consensus genomes showed high sensitivity and specificity. For smaller laboratories with limited infrastructure, we developed a flexible small-scale RT-qPCR platform to detect three signature mutations in a single run. The RT-qPCR platforms are important tools to support the control of the SARS-CoV-2 endemic in Denmark.

Keywords: RT-qPCR platforms; SARS-CoV-2; large-scale screening; national surveillance program; national surveillance system; signature mutations; variant PCR; variant of concern; variants of concern; whole-genome sequencing.
 
Back
Top Bottom